Werner syndrome (WS) is a rare autosomal recessive disorder characterized by a constellation
of adult onset phenotypes consistent with an acceleration of intrinsic biological aging. It is …

Mutations in WNK kinases cause the human hypertensive disease pseudohypoaldosteronism
type II (PHAII), but the regulatory mechanisms of the WNK kinases are not well understood…

By analysing the pathogenesis of a hereditary hypertensive disease, PHAII (pseudohypoaldosteronism
type II), we previously discovered that WNK (with-no-lysine kinase)–OSR1/SPAK …

With-no-lysine (K) (WNK) kinases have been identified as the causal genes for
pseudohypoaldosteronism type II (PHAII), a rare hereditary hypertension condition characterized by …

Pseudohypoaldosteronism type II (PHAII) is a hereditary disease characterized by salt-sensitive
hypertension, hyperkalemia and metabolic acidosis, and genes encoding with-no-lysine …

Background: Chronic kidney disease (CKD) accelerates vascular calcification via phenotypic
switching of vascular smooth muscle cells (VSMCs). We investigated the roles of circulating …

Upon activation by with-no-lysine kinases, STE20/SPS1-related proline–alanine-rich
protein kinase (SPAK) phosphorylates and activates SLC12A transporters such as the Na+-Cl− …

Dietary potassium intake is inversely related to blood pressure and mortality. Moreover, the
sodium-chloride cotransporter (NCC) plays an important role in blood pressure regulation …

Tolvaptan, a vasopressin type 2 receptor antagonist initially developed to increase free-water
diuresis, has been approved for the treatment of autosomal dominant polycystic kidney …

Background Gene identification of hereditary kidney diseases by DNA sequencing is important
for precise diagnosis, treatment, and genetic consultations. However, the conventional …